Healthcare provider profile · identity verified

Karan K Patel, M.D.

Family Practice · SAN LEANDRO, CA · NPI 1538511399

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	459	192
Amlodipine Besylate	Amlodipine Besylate	323	139
Lisinopril	Lisinopril	166	68
Tamsulosin Hcl	Tamsulosin Hcl	161	60
Losartan Potassium	Losartan Potassium	156	69
Metoprolol Tartrate	Metoprolol Tartrate	147	53
Albuterol Sulfate Hfa	Albuterol Sulfate	143	80
Levothyroxine Sodium	Levothyroxine Sodium	141	52
Metformin Hcl Er	Metformin Hcl	131	54
Simvastatin	Simvastatin	120	50
Metformin Hcl	Metformin Hcl	113	47
Omeprazole	Omeprazole	109	43
Gabapentin	Gabapentin	108	54
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	105	41
Hydrochlorothiazide	Hydrochlorothiazide	98	45
Furosemide	Furosemide	94	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	88	32
Fluticasone Propionate	Fluticasone Propionate	84	41
Glipizide	Glipizide	80	34
Trazodone Hcl	Trazodone Hcl	70	27
Pantoprazole Sodium	Pantoprazole Sodium	68	33
Atenolol	Atenolol	65	30
Duloxetine Hcl	Duloxetine Hcl	62	23
Alendronate Sodium	Alendronate Sodium	58	32
Metoprolol Succinate	Metoprolol Succinate	58	23
Jardiance	Empagliflozin	57	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	23
Famotidine	Famotidine	54	28
Potassium Chloride	Potassium Chloride	54	23
Alvesco	Ciclesonide	51	26
Lactulose	Lactulose	51	11
Hydralazine Hcl	Hydralazine Hcl	50	19
Ibuprofen	Ibuprofen	49	31
Pregabalin	Pregabalin	47	13
Allopurinol	Allopurinol	45	21
Tizanidine Hcl	Tizanidine Hcl	41	15
Cefadroxil	Cefadroxil	39	35
Terazosin Hcl	Terazosin Hcl	36	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	35	25
Finasteride	Finasteride	35	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Ozempic	Semaglutide	34	15
Humulin N	Insulin Nph Human Isophane	32	suppressed
Spiriva Respimat	Tiotropium Bromide	32	18
Wixela Inhub	Fluticasone Propion/Salmeterol	30	18
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	18
Montelukast Sodium	Montelukast Sodium	27	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	27	11
Baclofen	Baclofen	26	12
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Fluocinonide	Fluocinonide	26	15
Glipizide Er	Glipizide	26	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	12
Pravastatin Sodium	Pravastatin Sodium	25	12
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	25	suppressed
Clobetasol Propionate	Clobetasol Propionate	24	suppressed
Colchicine	Colchicine	24	12
Lovastatin	Lovastatin	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Carvedilol	Carvedilol	21	suppressed
Mirtazapine	Mirtazapine	21	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Acyclovir	Acyclovir	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Tramadol Hcl	Tramadol Hcl	18	suppressed
Nabumetone	Nabumetone	17	12
Propranolol Hcl	Propranolol Hcl	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	16	16
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Prednisone	Prednisone	16	11
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Naproxen	Naproxen	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	11
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	13	11
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error